❭ Action plans and policy papers ❭

Action plans and policy papers

Protocol: An anonymized GWAS to urgently query host genetic predisposition to severe COVID-19 (SARS-CoV-2 infection) lung disease (open as PDF)
Criteria for excellent research in KIT – report from work group (in Norwegian only) (open as PDF)
User involvement: possible models in KIT. Report from work group (in Norwegian only) (open as PDF)
Handlingsplan for forskning i KIT for 2021 (open as PDF)
Handlingsplan for forskning i KIT for 2022 (open as PDF)
Handlingsplan for forskning i KIT for 2023 (open as PDF)
 
Scroll to top

Home Div. of Surgery, Inflammatory Diseases and Transplantation

  • Research Institute of Internal Medicine
  • Research Management and the Research Committee
  • Action plans and policy papers
  • Strategisk protokollutvalg KIT
  • Annual reports
  • Research staff
  • Thematic areas

Recent publications

Karabeg M, Petrovski G, Holen K, Steffensen Sauesund E, Fosmark DS, Russell G, Erke MG, Volke V, Raudonis V, Verkauskiene R, Sokolovska J, Moe MC, Kjellevold Haugen IB, Petrovski BE (2025)
Comparison of Validity and Reliability of Manual Consensus Grading vs. Automated AI Grading for Diabetic Retinopathy Screening in Oslo, Norway: A Cross-Sectional Pilot Study
J Clin Med, 14 (13)
DOI 10.3390/jcm14134810, PubMed 40649184

Confalonieri F, Hertzberg SNW, Dziedzic KA, Lumi X, Lytvynchuk L, Znaor L, Petrovski G, Petrovski BÉ (2025)
Cost-Effectiveness of Alternative Treatment Strategies of Subretinal Macular Hemorrhage
Healthcare (Basel), 13 (13)
DOI 10.3390/healthcare13131550, PubMed 40648575

Augustin M, Bewley A, Brüggen MC, de Bruin-Weller MS, Ezzedine K, Ferrucci SM, Gkalpakiotis S, Herranz P, Johansson EK, Kampe T, Lapeere H, Legat FJ, Rehbinder EM, Szepietowski JC, Torres T, Vestergaard C, Werfel T, Domenech A, Massana E, Koscielny V, Narayanan S, Kasujee I, Gutermuth J (2025)
European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocol
BMJ Open, 15 (7), e102155
DOI 10.1136/bmjopen-2025-102155, PubMed 40645621

Melsom T, Brobak KM, Norvik JV, Enoksen IT, Rinde L, Jenssen TG, Eriksen BO (2025)
Iohexol clearance, but not estimated GFR, reveals a steeper GFR decline in patients with prediabetes
Kidney Int (in press)
DOI 10.1016/j.kint.2025.06.019, PubMed 40645290

More publications